Coronaphobia in Patients With Fibromyalgia.
Abstract Background: Throughout the world, the coronavirus disease (COVID-19) pandemic has had a significant effect on human health and daily life. Recent data in literature showed that the COVID-19 pandemic has increased mental health problems. One of these problems, including specific phobia called as “coronaphobia”. The aim of this study was to measure the level of specific phobia created by the COVID-19 pandemic in fibromyalgia (FMS) patients, and to compare this with levels of coronaphobia in patients without FMS.Results: Sixty-one patients participated in the study. Thirty patients diagnosed with fibromyalgia were included in the fibromyalgia group and 31 patients without a diagnosis of fibromyalgia in the control group. The sociodemographic data of all the patients and the presence of chronic disease were determined. All the patients in both groups were instructed to complete the COVID-19 Phobia Scale (C19P-S). The C19PS total score and psychological, psychosomatic, social, and economic subgroups scores were determined to be statistically significantly higher in the FMS group than in the control group (23.2 vs 16.3, 10.9 vs 7.1, 18.4 vs 12.1, and 10.5 vs 6.5 respectively).Conclusion: The results of this study demonstrated that FMS patients have more concerns in this extraordinary global pandemic situation. Early determination of COVID-19 phobia in individuals predisposed to psychological disorders, such as those with FMS, must be kept in mind in respect of providing timely psychological support and being able to keep the disease under control.